Nature's Sunshine Products (NATR) Expected to Announce Earnings on Thursday

Key Points

• Q1 2026 results are due after the market closes on Thursday, May 7 (earnings call at 5:00 PM ET); analysts expect EPS of $0.2111 and revenue of $122.736 million.
• The stock has seen multiple upward revisions — DA Davidson raised its target to $33 and Canaccord to $29 — and carries a consensus Buy rating with an average price target of $31.00.
• Company insiders have been net sellers recently (38,899 shares sold, about $951,206 in the last three months), while institutional investors own roughly 79.4% of the shares.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) will likely be announcing its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect Nature's Sunshine Products to post earnings of $0.2111 per share and revenue of $122.7360 million for the quarter. Investors may review the information on the company's upcoming Q1 2026 earning report for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:00 PM ET.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its quarterly earnings results on Tuesday, March 10th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.11. Nature's Sunshine Products had a return on equity of 14.36% and a net margin of 4.07%.The firm had revenue of $123.81 million for the quarter, compared to analysts' expectations of $121.62 million.

Nature's Sunshine Products Trading Down 0.6%

Shares of NATR stock opened at $27.03 on Thursday. The company has a market capitalization of $473.24 million, a P/E ratio of 25.50 and a beta of 0.92. The business's 50 day moving average is $25.73 and its two-hundred day moving average is $22.59. Nature's Sunshine Products has a twelve month low of $11.70 and a twelve month high of $28.14.

Analyst Upgrades and Downgrades

NATR has been the subject of several analyst reports. DA Davidson increased their price target on shares of Nature's Sunshine Products from $23.00 to $33.00 and gave the stock a "buy" rating in a report on Thursday, March 12th. Canaccord Genuity Group boosted their target price on Nature's Sunshine Products from $22.00 to $29.00 and gave the stock a "buy" rating in a research report on Tuesday, March 10th. Finally, Weiss Ratings raised Nature's Sunshine Products from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Friday, March 20th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $31.00.

Insider Activity at Nature's Sunshine Products

In other Nature's Sunshine Products news, CAO Jonathan David Lanoy sold 4,000 shares of the company's stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $24.70, for a total value of $98,800.00. Following the sale, the chief accounting officer owned 46,405 shares of the company's stock, valued at $1,146,203.50. This represents a 7.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Daniel C. Norman sold 15,383 shares of the stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $24.52, for a total transaction of $377,191.16. Following the completion of the sale, the executive vice president owned 55,693 shares in the company, valued at $1,365,592.36. This represents a 21.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 38,899 shares of company stock valued at $951,206. Insiders own 3.10% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC boosted its stake in shares of Nature's Sunshine Products by 2,113.6% during the third quarter. NewEdge Advisors LLC now owns 15,606 shares of the company's stock valued at $242,000 after acquiring an additional 14,901 shares during the last quarter. Verdad Advisers LP acquired a new position in Nature's Sunshine Products in the 4th quarter valued at about $242,000. Jane Street Group LLC raised its stake in Nature's Sunshine Products by 18.4% in the 2nd quarter. Jane Street Group LLC now owns 16,369 shares of the company's stock valued at $242,000 after purchasing an additional 2,538 shares during the last quarter. Amundi lifted its holdings in Nature's Sunshine Products by 252.2% in the 2nd quarter. Amundi now owns 15,429 shares of the company's stock valued at $234,000 after purchasing an additional 11,048 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD purchased a new position in Nature's Sunshine Products in the 4th quarter valued at about $232,000. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Nature's Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.